Meeder Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-134
Closed -$9K 1852
2022
Q3
$9K Sell
134
-16
-11% -$1.37K ﹤0.01% 1369
2022
Q2
$11K Sell
150
-1,195
-89% -$77K ﹤0.01% 1351
2022
Q1
$107K Buy
1,345
+1,198
+815% +$89.2K 0.01% 778
2021
Q4
$13K Sell
147
-2,523
-94% -$271K ﹤0.01% 722
2021
Q3
$343K Buy
2,670
+239
+10% +$33.4K 0.02% 581
2021
Q2
$371K Buy
2,431
+1,330
+121% +$175K 0.02% 586
2021
Q1
$117K Buy
+1,101
New +$110K 0.01% 880
2019
Q1
Sell
-1,188
Closed -$37K 1844
2018
Q4
$37K Sell
1,188
-61
-5% -$2.38K ﹤0.01% 895
2018
Q3
$60K Sell
1,249
-419
-25% -$17.2K ﹤0.01% 747
2018
Q2
$51.7K Buy
1,668
+1,556
+1,389% +$36.4K ﹤0.01% 748
2018
Q1
$2K Hold
112
﹤0.01% 1397
2017
Q4
$2K Buy
+112
New +$1.66K ﹤0.01% 1506

Other funds holding STAA

Meeder Asset Management's STAA Position: Q4 2022 in Review

Meeder Asset Management sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 134 shares — an estimated $9K sold.

Meeder Asset Management first reported a position in STAA in Q4 2017 and held it in 12 quarters. The position peaked at $371K in Q2 2021. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • Meeder Asset Management reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 134 STAAR Surgical shares in Q4 2022, an estimated $9K.
  • Meeder Asset Management first reported a position in STAAR Surgical in Q4 2017 and held it in 12 quarters.
  • Meeder Asset Management's STAAR Surgical position peaked at $371K in Q2 2021.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.